FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Peregrine Reports Positive Data from Lung Cancer Trial

[ Price : $8.95]

Peregrine Pharmaceuticals reports favorable Phase 2b study data in patients with refractory non-small cell lung cancer that showed...

FDA Clears Precision Spine Cervical Plate System

[ Price : $8.95]

FDA clears a Precision Spine 510(k) for the Slimplicity Solo Anterior Cervical Plate System for use in cervical spine procedures.

Geron Discontinues Imetelstat Breast Cancer Trial

[ Price : $8.95]

Geron stops a randomized Phase 2 study involving imetelstat in metastatic HER2-negative breast cancer because median progression-f...

FDA Clears Abiomed Impella CP

[ Price : $8.95]

FDA clears an Abiomed, Inc. 510(k) application for the Impella CP, a percutaneous catheter-based heart pump.

FDA Withdraws 4 NADAs

[ Price : $8.95]

Federal Register Final rule: FDA amends the animal drug regulations to withdraw four NADAs that are no longer marketed.

Drug Shortage Tide is Ebbing: Report

[ Price : $8.95]

An NBC News report says the pace of new drug shortage reports seems to be slowing.

Genentech Survives Preemption Argument in Raptiva Injury Case

[ Price : $8.95]

An appeals court affirms a lower court decision that claims brought in a consolidated products liability suit involving Genentechs...

Generic Drugs and Drug Quality Elevated in CDER Reorganization

[ Price : $8.95]

A proposed reorganization by CDER director Janet Woodcock elevates the Office of Generic Drugs to a super office and plans a new o...

CDRH Outlines Actions to Strengthen Postmarket Surveillance

[ Price : $8.95]

A just-posted CDRH white paper outlines four specific actions the Center plans to focus on to strengthen its medical device postma...

AstraZeneca Scraps Obesity Drug Candidate

[ Price : $8.95]

AstraZeneca stops developing a weight-loss compound designated AZD2820 due to safety concerns.